Machelle Sanders
CIK: 0001718020
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Aug 3, 2026FTRE
Fortrea Holdings Inc.
Sale(S)Direct9.7K shares at avg. $18.01$175K - Jun 11, 2026BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct15.3K shares- - Jun 10, 2026FTRE
Fortrea Holdings Inc.
Award(A)DirectRestricted Stock Unit
12.9K shares- - Jun 10, 2026FTRE
Fortrea Holdings Inc.
Exercise(M)Direct38.8K shares- - Nov 13, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Sale(S)Direct9.6K shares at avg. $7.14$69K - Jun 12, 2025BCRX
BIOCRYST PHARMACEUTICALS INC
Award(A)Direct12.5K shares- - Jun 10, 2025FTRE
Fortrea Holdings Inc.
Award(A)DirectRestricted Stock Unit
38.8K shares- - May 14, 2025FTRE
Fortrea Holdings Inc.
Exercise(M)Direct7.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  FTRE Fortrea Holdings Inc. | Sale(S) | 9,700 | $18.01 | $174,697 | Direct |
| Jun 11, 2026 |  BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 15,294 | - | $0 | Direct |
| Jun 10, 2026 | FTRE Fortrea Holdings Inc. | Award(A) Restricted Stock Unit | 12,852 | - | - | Direct |
| Jun 10, 2026 | FTRE Fortrea Holdings Inc. | Exercise(M) | 38,817 | - | $0 | Direct |
| Nov 13, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Sale(S) | 9,600 | $7.14 | $68,544 | Direct |
| Jun 12, 2025 | BCRX BIOCRYST PHARMACEUTICALS INC | Award(A) | 12,500 | - | - | Direct |
| Jun 10, 2025 | FTRE Fortrea Holdings Inc. | Award(A) Restricted Stock Unit | 38,817 | - | - | Direct |
| May 14, 2025 | FTRE Fortrea Holdings Inc. | Exercise(M) | 7,282 | - | - | Direct |
1-8 of 8 transactions
About SANDERS MACHELLE
SANDERS MACHELLE (SEC CIK 0001718020) files insider reports with the SEC as Director of Fortrea Holdings Inc. (FTRE) and Director of BIOCRYST PHARMACEUTICALS INC (BCRX).
Signal8 holds 7 ownership filings by SANDERS MACHELLE, all Form 4s, filed between May 16, 2025 and Aug 5, 2026. Those filings report 8 transactions, from May 14, 2025 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SANDERS MACHELLE's filings is in DURHAM, NC.
Recent filings by SANDERS MACHELLE
- Aug 3, 2026: Open-market sale of FTRE shares (Form 4, code S).
- Jun 11, 2026: Grant or award of BCRX shares (Form 4, code A).
- Jun 10, 2026: Grant or award of FTRE derivative securities (Form 4, code A).
- Jun 10, 2026: Option exercise of FTRE shares (Form 4, code M).
- Nov 13, 2025: Open-market sale of BCRX shares (Form 4, code S).
Other insiders filing for Fortrea Holdings Inc. (FTRE)
- Knoblauch Jason Fredrick, Chief Financial Officer
- Russell Carrie Elizabeth, Interim CAO
- Morais Mark A., Chief Operating Officer
- Thakral Anshul, Chief Executive Officer
- Smith David Ross, Interim CFO
- Pesicka Edward A, Director